Aradhana Tiwari

Aradhana Tiwari has a diverse work experience in the field of precision medicine, immuno-oncology, and research. Aradhana currently works as a Precision Medicine Scientist at Sema4, where they serve as a Somatic Variant Curator for NGS exome and transcriptome in solid and heme tumors. In this role, they collaborate with clinical research teams, physicians, and the knowledge base team to interpret clinical reports and provide clinical advice based on genomic sequencing data. Prior to this, they worked as an Assistant Professor at New York Medical College for eight years, specializing in immuno-oncology R&D and contributing to the development of potential drug trial candidates. Aradhana also has experience as a Research Scientist and Postdoctoral Fellow at the Blood Center of Wisconsin and the University of Alberta, respectively. Earlier in their career, they served as an Academic Staff member at Fukuoka University, focusing on the mechanisms of beta amyloid accumulation in the brain and developing HLA Tetramer technology for early tumor antigen detection. Overall, Aradhana Tiwari's work experience spans various research and academic positions, with a particular focus on precision medicine and immuno-oncology.

Aradhana Tiwari holds a Master of Public Health (MPH) degree, specializing in Health Policy and Management, as well as Global Health from New York Medical College. Additionally, they have a Doctor of Philosophy (PhD) degree from Central Drug Research Institute, RML Awadh University. Furthermore, they have a Master of Science (MS) degree from the University of Lucknow and has pursued a Post Doctoral program from the NII - National Institute of Immunology. Aradhana completed their Bachelor of Science (BS) from the University of Lucknow.